URGENT: Critical Senate Vote On Historic Marijuana Legislation Only Weeks Away?
The Biggest Investment Opportunity in the History of Legal Marijuana
This Ground-Breaking Discovery is About to Revolutionize the Marijuana Industry…
and Deliver Gains of $154,445 or More to
Early Investors
Dear Reader,
Take a close look at the photograph above.
The golden liquid you see inside the technician’s gloved hand is about to hit the legal marijuana industry like a Category 5 hurricane.
It will put every existing pot company on high alert…
And create a rare opportunity for everyday investors like you to add $154,445… $308,889… or even as much as $617,778… to your account depending on how much you invest.
You see, scientists have just discovered how to produce marijuana’s active ingredients — THC and CBD — inside a laboratory.
Business Insider confirms:
Bloomberg News recently asked:
And Cronos Group CEO, Mike Gorenstein predicts marijuana companies without this technology will be competing in:
This cutting-edge discovery will allow a pot company to produce more THC and CBD in a single day than an old school “grow-op” can produce in a year.
Not only will it be faster to produce…
It will also be cheaper…
And as pure and potent as any medicine you’d find in a hospital pharmacy.
Make no mistake…
Every pot company in the world is desperate to get its hands on this technology.
And I’ve just uncovered the one company that’s perfectly positioned to be the first…
Delivering gains of up to 6,077% to investors who take action today.
Because a Senate vote in the next few weeks could send the company’s stock price into the stratosphere…
And make you wealthier than you ever thought possible.
Imagine paying off your mortgage…
Buying ‘his’ and ‘hers’ Cadillacs for you and your spouse…
Taking your extended family on a ’round-the-world’ vacation…
Or maybe even sending your grandkids to Ivy League colleges.
That’s the kind of money that could be at stake here.
So, it’s critical you pay close attention to the information I reveal in the next few minutes, because…
This “Marijuana Miracle” Won’t Remain a Secret for Long
The discovery I’m sharing today is brand new.
It was developed by a team of PhD-level scientists at the University of California, Berkeley just a few months ago.
And it won’t be long before it becomes front-page news.
You see, the lab technician holding the test tube in this photo doesn’t work for a “pot” company.
She works for a biotech company.
And for the past 20 years, the biotech and biopharma industries have been at the forefront of making new discoveries…
Turning those discoveries into patentable medications…
And delivering life-changing wealth to investors.
Here’s an example…
A 6,077% Return From a
Single Drug Discovery
Back in 1972, a scrappy, up-and-coming bio-pharmaceutical company was listed on the New York Stock Exchange at $0.81 a share.
And for the first 10 years, it limped along…
Producing the same old prescription drugs, the same old way.
Its stock barely broke the $1 mark only a handful of times.
But one day in the 1990s, the company stumbled onto the formula for the little blue pill we now know as Viagra…
And everything changed overnight.
By the time Viagra received FDA approval, the company’s stock was trading just under $32.
And about a year later, it reached a high of $50.04.
The company of course, was Pfizer.
And in the past 15 years, Viagra has generated world-wide sales of over $27 billion.
So if you’d taken a $10,000 stake in Pfizer before its Viagra discovery changed the world for tens of millions of men and their partners…
You’d have been sitting on almost $617,778 a few short years later.
Now, drug discoveries like Viagra don’t happen every day.
They’re like lightning strikes.
Which is why when they happen…
Early investors get obscenely wealthy.
And that’s exactly the type of opportunity you have in front of you today…
The chance to be an early investor in a discovery that will transform an entire industry…
Bring much-needed relief to millions of suffering Americans — including children and military veterans…
And allow you to reap the lion’s share of the spoils in the process.
Now, if you’re wondering why you haven’t heard about this breakthrough pot discovery until now, it’s because…
Two Powerful Groups Conspire to Keep Information (And Profits) Out of Your Hands
If you’ve missed investment opportunities like this in the past because you learned about them too late…
Don’t beat yourself up.
The unfortunate reality is… the system is rigged against the everyday investor.
Critically important information like I’m sharing with you in this presentation gets hidden from the public almost every day.
You see, two powerful groups…
Wall Street insiders and the mainstream media are in cahoots.
When Wall Street finds a huge profit opportunity…
They solicit the media to sit on the information… sometimes for months.
The media is happy to stay quiet, line their pockets, and comply with Wall Street’s whims.
And once Wall Street has sucked as much money out of the opportunity as they can…
Only then do they give newspapers and television networks the green light to release the news to the public.
That’s how Wall Street insiders and their mainstream media minions stay fat and rich.
While “outsiders” — millions of hardworking Americans — are left to fight over the few profit scraps they leave behind.
If any of that sounds unfair, you’re absolutely right…
It’s not fair.
And that’s exactly why you need someone in your corner…
Doing the heavy lifting for you…
Finding the “secrets” Wall Street banks, hedge funds, and the mainstream media normally keep to themselves…
And fighting to get those secrets in your hands while you still have time to make a killing from them.
That’s exactly what I’ll do in this presentation.
In just a moment, I’ll reveal all the details of this breakthrough marijuana discovery…
The company at its epicenter…
Plus, how you can use this information today to claim your share of the billion-dollar profit opportunity that’s coming.
But first, let me introduce myself…
I’m John Persinos…
and I’m Not Like the Financial “Gurus”
You’ve Heard from in the Past
In fact, many of those gurus consider me an “outsider.”
You see, I don’t belong to a private country club.
I don’t hobnob with financial news celebrities.
And I don’t have a reputation for making “crystal ball” predictions on the future price of oil…
The level of interest rates…
Or the collapse of American civilization.
Instead of offering theoretical financial advice, I’m a “boots-on-the-ground” investigative financial journalist.
I’ve spent over 30 years writing for underground, off-the-radar financial publications…
Turning over stones to uncover information Wall Street brokers ignore…
Fine-tuning my instincts for identifying the best investment opportunities in the market…
And bringing those opportunities to everyday investors like you.
Over the past 30+ years, I’ve seen, heard, and written about thousands of opportunities.
But the one I’m sharing with you today has the potential to make them all look like tiny blips in comparison.
Let me explain why…
Better Than the Real Thing in Every Way… Including the Returns You Could See
It’s extremely rare to find a Viagra-style breakthrough discovery before it turns an entire industry upside down.
But that’s exactly what I’ve just done.
You see, for the past five years, a team of brilliant scientists and engineers had been trying to do the impossible…
Create marijuana’s active ingredients — the “cannabinoids” THC and CBD — in a lab without ever touching a cannabis plant.
Why would they want to avoid the plant?
Well, growing marijuana is horrendously inefficient and outrageously expensive.
Even if you ignore the cost of real estate, water, fertilizer, pesticides, and security…
All of which are major expenses for even the smallest marijuana producer…
The cost of electricity alone is overwhelming.
The marijuana industry in California — America’s top-producing state — consumes 3% of the entire country’s electricity.
In fact, electricity adds $5,500 per pound to the cost of finished marijuana products.
For California, that amounts to over $85 billion a year in electricity costs… and that’s just one state.
On top of that, it also takes four to five months to grow and harvest a marijuana plant.
In contrast…
Imagine a pot company that could throw a bag of powder into a stainless-steel tank…
Add a little water…
Close the cover…
And a day or two later have more 100% pure THC or CBD than a grow-op can produce in 12 months.
As incredible as that scenario might sound… it’s not science fiction.
Lab-made marijuana will REVOLUTIONIZE how cannabinoids are produced.
And it won’t be long before the entire end-to-end process is completely automated…
With the company creating 24-hour-a-day streams of pharmaceutical-grade THC and CBD that…
Are 100% pure…
Contain no contaminants…
Cost pennies to produce…
And are ready to ship within days.
Let me repeat that…
100% pure. Toxin-free. Cheaper to produce. And ready in days.
And best of all…
These lab-made cannabinoids aren’t cheap knockoffs of the real thing…
They ARE the real thing.
And because they’re made in a laboratory under “hospital operating room” conditions…
They’re cleaner and safer than any chemical extracted from a plant grown in soil.
In fact, they’re pharmaceutical grade…
As pure and as potent as any prescription medication you’d pick up at a pharmacy or be given through an intravenous tube in a hospital.
Make no mistake…
This discovery has created a once-in-a-generation investment opportunity.
The impact it has on the world economy will rival the cotton gin, the assembly line, and the Internet.
And if you play this opportunity correctly, you could add a quick six-figures or more to your investment account, because…
Biotechnology Companies Generate
Explosive Gains
Most Americans list “health” as their number one life concern.
It’s the main reason healthcare is an $8.7 trillion a year industry here in the U.S.
It’s also one of the reasons companies who develop drugs to prevent and treat life-threatening and debilitating illnesses often generate remarkable investment returns.
Here are just a few examples…
Vertex… known for its Hepatitis C medication, delivered gains of 2,334%…
Investors in Seattle Genetics, which specializes in cancer treatments, saw a 3,578% return…
Incyte Corp. — with only a single drug on the market — delivered 7,347%…
Alexion Pharmaceuticals, focusing on treatments for rare life-threatening disorders… showed investors an astounding 8,560% return…
And Celgene Corporation — creator of treatments for cancer and inflammatory diseases — delivered savvy investors a jaw-dropping 45,688% gain…
If you’d invested as little as $5,000 in each of these five companies…
Today, you could have an extra $3.4 million in the bank.
Just imagine how that kind of money would change your life forever.
You could get yourself that mid-engine sports car you’ve always wanted….
Buy a second (or third) home…
Maybe even pay off your kid’s mortgages… what an amazing gift that would be.
But, however you choose to spend your money…
You’d have the freedom to indulge yourself and your family in any way you want… without having to make financial sacrifices in other areas.
Now, I can’t guarantee you’ll see returns exactly like these… after all, there’s risk involved with every investment.
What I can guarantee is this…
When you combine an outstanding company and a remarkable discovery…
Returns can be life changing.
And the discovery I’m sharing today has the potential to be the biggest opportunity of our generation.
Because unlike the companies I’ve just shown you…
This discovery doesn’t just offer a single treatment for a single medical condition.
Instead, it will disrupt an entire $82 billion a year industry…
And create an investment opportunity that could put your retirement on easy street.
That’s not wishful thinking…
The company with this technology could easily produce THC and CBD…
- Purer than any competitor…
- Cheaper than any competitor, and…
- Faster than any competitor
That combination could explode stock prices overnight and turn the company into a household name within days.
The biotech returns I’ve just shown you are excellent examples of how the stock market rewards companies who use innovative technologies to create radical new medical treatments.
They’re also great examples of how the market rewards investors who own stock in those companies.
And I’ve just uncovered the marijuana industry’s equivalent…
The Company that’s About to Become
“The Pfizer of Pot”
When Pfizer discovered Viagra in the 1990, it rewarded investors with gains of up to 6,077%.
Turning every $1,000 invested into $61,770…
And every $5,000 into $308,850.
Well, the company I’ve uncovered is well on its way to becoming the “Pfizer of the pot industry.”
But to call them a “pot company” really doesn’t do them justice.
Because unlike most pot companies, this one doesn’t operate in the recreational market at all.
Their sole focus is on using cannabinoids — THC, CBD, and others — to produce radical new prescription medicines.
Unlike the “Big Pharma” names you’re likely familiar with… Johnson & Johnson, Merck, Pfizer, and Eli Lilly…
The company I’m following is just over 18 years old…
It’s not brand new… so it’s successfully moved past the growing pains many companies experience in their first few years.
At the same time, it’s not so old that the market has drained away all the profit potential.
I refer to it as an early-stage biotech.
And “early-stage” is the best time to invest in a biotech company…
It means there’s plenty of time and opportunity for it to develop into one of the industry’s big players.
It also means you can still buy stock at reasonable prices.
But the biggest difference between this company and its competition is…
It’s one of the few companies on the planet developing and marketing cannabis-based prescription medications.
Sure, there are a few scrappy startups wading into the “pool” (and I’m keeping an eye on every last one of them)…
But if my research is correct (and I’m confident it is), we could be just weeks away from the “Pfizer of Pot” becoming a household name…
And seeing its stock price soar as much as 6,077%.
Also… unlike the startups I just mentioned, this company has been actively developing breakthrough medications for almost 20 years.
Their top executives have a well-established track record with the FDA to review and approve the innovative drugs they’ve developed.
Virtually no other company in the cannabis medication space can make that claim today.
This puts them in a unique position where they’re able to remain laser-focused on the things they’re good at, like…
- Finding new ways to extract cannabinoids with greater purity
- Innovative ways of administering these medications to patients
- And identifying debilitating medical conditions they can prevent and treat
That focus is proving to be a magic formula because…
Patent Revenue Could Turn This Biotech into a Cash Flow Machine
Patents are the lifeblood of every biotech company.
They’re like hundred-foot fortress walls built of solid granite…
Covered top to bottom in razor blade barbed wire…
And surrounded by a 100-foot moat… teaming with alligators.
When a biotech company develops a new medication, a new production method, or identifies a new illness they can prevent or treat…
Patents give them a virtual monopoly…
Allowing them to slam the door shut on their competition…
And charge practically any price they want for a period of 20 years.
Best of all… their 20-year monopoly is protected by U.S. law.
Now, it may not seem fair that drug companies can legally gouge us for medications we need to stay healthy.
I don’t like it either.
And it’s something both sides of the political aisle in Washington, D.C. are doing their best to fix.
In the meantime, one way to guarantee you and your family can afford the medications you need is to claim your share of the patent revenue these companies are generating.
And in just a minute, I’ll show you exactly how to do that.
The good news is that right now, the company I’m following has active patents for cannabis-based medications to prevent and treat serious medical conditions including:
- Alzheimer’s disease
- Parkinson’s disease
- Multiple Sclerosis
- Prostate cancer
- Breast cancer
- Colon cancer
- Psychotic disorders
- Obesity
- Epilepsy
All-in-all, patents are the most valuable asset any pharmaceutical company can own.
Here are just a few examples of patented medications that have generated billions for other biotech and pharmaceutical companies…
Bristol-Myers Squibb’s stroke prevention medication Plavix has generated lifetime sales of over $83 billion.
Johnson & Johnson’s arthritis drug Remicade produced over $90 billion.
GlaxoSmithKline’s asthma treatment Advair has raked in over $95 billion.
AbbVie’s anti-inflammatory drug Humira generated over $109 billion.
And Pfizer’s high cholesterol drug Lipitor is responsible for more than $150 billion in lifetime sales.
In total, the company I’ve uncovered owns 62 patents and has another 76 applications awaiting approval from the U.S. Patent Office.
Imagine how much the company’s patents for treating illnesses like Alzheimer’s, Parkinson’s, Multiple Sclerosis, cancer, obesity, and epilepsy could be worth.
Given the massive profits other pharmaceutical companies have generated with their patented drugs…
Each patent could be worth tens of billions…
Send the stock price soaring…
And add $156,445… $308,889… or even as much as $617,778… to your retirement account.
Now, returns like this are rare…
So when you’re presented with an opportunity like the one I’m sharing today…
It’s important you take full advantage of it as soon as humanly possible…
Because the company’s current patents are just the tip of the iceberg…
Lab-Made Marijuana Could Create
Hundreds of Radical New Drugs
The best-known cannabinoids are THC and CBD.
THC produces the intoxicating “high” marijuana is famous for.
And studies have shown CBD can reduce pain, anxiety, depression, blood pressure, inflammation…
And potentially help prevent diabetes, reduce the spread of cancer cells, and even help opioid addicts kick their habits.
In just these two compounds alone, there’s potential for dozens of patentable medications…
And billions of dollars in profits.
But cannabis contains more than 100 different cannabinoid compounds.
Most of them are in such low concentrations in the cannabis plant that extracting them is too expensive to even attempt.
Thankfully, that’s a problem lab-made pot can easily solve.
In the laboratory, our biotech will have the ability to produce any one of these 100+ cannabinoids…
In large quantities…
Within days…
And with 100% purity.
Better, cheaper, and faster than their competition.
Here are just a few examples of these lesser-known cannabinoids and their potential medical uses:
- CBG — Stimulate appetite, bone growth, and brain cell development. Suppress cancer cell growth. Reduce insomnia, inflammation, and seizures.
- CBN — Sedative. Has anti-bacterial properties. Treatment for psoriasis and burns. Heal broken bones and treat osteoporosis.
- THCA — Reduce nausea and inflammation.
- CBC — Improve bone growth. Reduce pain and inflammation. Treat migraines. Reduce tumor growth.
- CBDA — Reduces inflammation. Anti-microbial.
- THCV — Appetite suppressant. Anti-convulsive. Reduce blood sugar levels in diabetics.
Discovering an illness that responds well to one of these compounds could easily result in a new patent worth tens of billions to our biotech firm…
And boost its stock price even higher with each new patent they file.
There’s no question that drug patents will be the foundation of the company’s revenues.
But if they succeed in their bid to patent the production method…
A Production Method Patent Could Turn
The Company into an Unstoppable
Industry Gatekeeper
It won’t surprise you to know it’s not possible to patent naturally occurring compounds like THC and CBD.
That would be like trying to patent Vitamin C, peanuts, or coconut milk.
Most materials nature gives us for free are non-starters with the U.S. Patent Office.
What can be patented is a production process like the one researchers recently discovered…
The precise method they used to produce 100% pure THC and CBD in a stainless-steel tank is something that can be granted exclusive protection for 20 years.
As soon as this process becomes commercially available…
Any pot company still planting seeds in the ground will be fighting a machine gun battle with a BB gun.
There’s no way they’ll be able to compete with the purity, quantity, cost, or production speed of lab-made THC and CBD.
In order to survive, every marijuana company on the planet will need this technology…
And the company who owns the patent…
They’ll become the gatekeeper of a $82 billion a year industry.
They’ll decide who gets access to the technology…
And they’ll decide how much they charge for access.
The bottom line is this…
With a patent on the production method, our little biotech could generate tens of billions a year in licensing fees.
And that’s on top of the revenue they generate from drug sales.
A “gatekeeper” patent could push the company’s stock far beyond any of the “Big Pharma” or biotech gains we’ve seen in the past…
And set you up with the stress-free, luxury retirement you deserve.
But if you think the current legal status of marijuana makes these returns years away…
And you have plenty of time to mull over buying stock in this company…
Here are few facts that might change your mind…
Marijuana Legalization is Barreling Toward Us Like a Freight Train
Right now, 18 states and Washington, D.C. have fully legalized marijuana for adult recreational use…
And a total of 36 states have legalized medical marijuana.
It’s not yet legal at the federal level but…
Former House Speaker and lifelong Republican John Boehner famously went on record to say this about federal marijuana legalization:
Mr. Boehner — who once described himself as “irrevocably-opposed” to marijuana — doubled-down on his revised opinion in 2018 when he became director of Acreage Holdings, a major player in the global cannabis industry…
And proudly let America know his “thinking on cannabis has evolved.”
Even Dr. Scott Gottlieb, during his time as commissioner of the Food and Drug Administration under President Trump, went on record in support of cannabis-based medicines…
A recent poll found 60% of Americans support full marijuana legalization at the federal level.
And 91% of Americans support legalization for medical purposes.
In mid-2021, the U.S. Drug Enforcement Agency announced it would soon certify new companies to grow marijuana plants for medical research…
The first time it’s done so in over 50 years.
When you put the facts together and consider:
- A growing number of Americans — including many conservative members of Congress — support marijuana legalization
- Canada recently became the largest country in the world to legalize it federally
- And Mexico is on its way to doing the same…
There’s only one conclusion you can reach…
That marijuana legalization is closer to a “sure thing” right now than it’s ever been.
But the most important and powerful fact of all is this…
The House of Representatives Has Passed the Most Important Marijuana Act in U.S. History
In late 2019, the House voted 321 to 103 in favor of the S.A.F.E. Banking Act.
The Act will allow marijuana companies access to banking and financial services even while pot remains illegal under federal law.
Not surprisingly, marijuana stocks spiked higher on the news.
As you’re well aware, the COVID-19 crisis prevented the Act from going to the Senate in 2020.
But now that the country’s beginning to stabilize…
We could be only weeks away from a Senate vote…
And that could easily be the single biggest step toward federal legalization in our country’s history.
With such an overwhelming House win — almost half the Republican representatives voted in favor — a Senate win is all but certain.
So it’s important you claim your share of this biotech firm as soon as possible.
Waiting to see how the Senate vote plays out is the wrong move.
By the time the Senate passes the Act, it will be too late.
Wall Street insiders will have already gobbled up the biggest slices of the pie…
And left you with only a few crumbs.
Here’s How to Get Started Today…
All the facts I’ve just shown you point in one direction…
Whether you’re for or against marijuana legalization, it’s coming…
And it will be here sooner than you think.
If you own the right stocks before legalization is announced, you’ll have an opportunity to create generational wealth for yourself and your family.
Even a modest stake in this biotech could shoot your net worth into the top 5% of Americans within weeks.
I’d love to see you in the top 5%…
And I want to help you get there.
That’s why I’ve created a special report titled The “Pfizer of Pot”: How One Surprising Biotech Could Add $308,850 To Your Retirement Account.
And in just a moment, I’ll show you how to get this report in your hands today.
Inside, you’ll discover:
- Full details on the company — including revenue projections and stock price forecasts — for both the next 12 months and longer term… so you’ll see exactly how big this opportunity is.
- Descriptions of the breakthrough medications they’ve already launched, how these drugs are changing the lives of patients in the U.S., U.K., and Europe… and how this points to higher short-term stock prices even while pot remains federally illegal.
- The patents that will cement them as the industry leader in the cannabinoid medication niche for decades to come… (Remember, patents could generate hundreds of billions in protected revenue… enough to skyrocket the stock price quickly and keep it there for years.)
- How federal marijuana legalization will open a flood gate of cash and turn the company into “The Pfizer of Pot” almost overnight… so you’ll understand why taking action immediately is the right move.
- Plus, the name of the company and details of their incredible team of world-class researchers… who are pursuing marijuana medication breakthroughs the company can patent and leverage to generate profits decades into the future.
- And most importantly, exactly how to play this stock — when to buy and at what price… so you won’t have to wonder if you’re doing the right thing.
If I were selling this report on its own, I’d charge $99 without a second thought.
After all, precise instructions on how to potentially add hundreds of thousands to your investment account is easily worth $99.
In fact, it’s worth many times that amount.
But today, I’d like to send you this report absolutely free.
You see, one of my greatest pleasures in life is helping people become wealthy.
And when I uncover an opportunity of this magnitude…
I want to share it with as many people as possible.
With $82 billion a year on the line… lab-made cannabinoids will generate wealth for millions of people.
To claim your stake, you only have to make one simple decision today…
And accept this free report.
But before I show you how to do that, there are two bonuses I’d like to send you.
BONUS REPORT #1:
How To Collect Up To $55,362 Every Year
From The Legal Marijuana Boom
As ex-House Speaker John Boehner says, marijuana legalization “is a matter of when, not if.”
The moment the DEA reclassifies marijuana, the market for cannabis-based medications will explode.
Hundreds of new companies could launch overnight…
All trying to discover a new patentable medication that will generate billion-dollar cash flows for the next 20 years.
Every one of these companies will need specialized facilities…
With proper security, ventilation, and climate control…
Processing rooms and storage warehouses…
And compliance with strict regulations imposed by the DEA, FDA, and other government agencies.
As you can imagine, setting up a facility like this can be incredibly expensive for a new firm.
But I’ve just uncovered a unique company that specializes in building and leasing exactly these types of facilities to licensed marijuana startups.
In this report, I reveal:
- The 60-year-old law that requires the leasing company to distribute 90% of its profits to shareholders every year.
- The company’s stellar payout history… and how it increased an astounding 368% in a little over two years.
- Two ways you can claim your share of the payout today… starting for as little as $100.
BONUS REPORT #2:
The Top 10 Under-The-Radar Winners to Outsmart the Market in 2021
Inside this gem of a report, you’ll discover 10 of my team’s top stock picks for 2021. These are companies that get completely ignored by most Wall Street analysts… mainly because they do just fine without greedy bankers meddling in their business.
This premium report reveals the precise details you need to take advantage of these “under-the-radar” profit streams this year, and well into the future.
Your “Pfizer of Pot” report and two bonus reports have a combined value of $217.
But I want to send you all three today as my free gift to you.
All I ask is that you accept a risk-free trial membership in my premier investment advisory.
It’s called Personal Finance…
And I’m opening the doors for you to join, today.
Personal Finance isn’t like other investment services.
Instead of a single “guru” offering investment opinions and recommendations…
Personal Finance consists of a team of four top-notch analysts:
Jim Pearce, Robert Rapier, Jim Fink, and myself… John Persinos.
Between us, we have over 110 years of “in the trenches” experience helping investors like you make money.
We have a single goal with Personal Finance and it’s one we take very seriously…
To help you become incredibly wealthy.
We’re not satisfied delivering mediocre returns that just barely beat the market.
Instead, Personal Finance is designed to present you with opportunities to generate life-changing fortunes…
Just like the ones you’ll discover inside the three reports you’ll receive today…
- The “Pfizer of Pot”: How One Surprising Biotech Could Add $308,850 To Your Retirement Account
- How To Collect Up To $55,362 Every Year From The Legal Marijuana Boom
- The Top 10 Under-the-Radar Winners to Outsmart the Market in 2021
But I want to make one point perfectly clear…
As excited as I am about the marijuana biotech opportunity I’m sharing with you today, Personal Finance isn’t a marijuana-only advisory service.
In fact, it’s not just a pharmaceutical or biotech stock advisory either.
My team and I analyze the economy, the markets, and individual stocks day in and day out.
And we work tirelessly to bring members the very best stock picks in the market… no matter what industry they’re in.
Here’s a small sample of the profits my team has delivered our readers…
508% on Bayer…
108% on Barrick Gold…
503% on multi-national alcohol producer Diageo…
391% on Dominion Energy…
118% on Johnson & Johnson…
163% on Microsoft (MSFT)…
And 479% on Apple…
The Personal Finance team often receives letters and emails from people all around the country who’ve followed our recommendations and are eager to share their results.
They include Martin Fowler who’s made “a lot of money…”
Ben Werner told me he regularly sees gains of over 300%.
Tim Graybill says he’s up $63,000 this year.
Maryann Myers let me know she went from being broke to having nearly half a million dollars thanks to our work.
And Glen Carter has used his membership to grow a seven-figure portfolio…
Now, some of these results are exceptional and there’s no way I can guarantee you’ll see similar wins.
But every comment I’ve shown you above was sent to us by an everyday investor just like you…
Each of them made a bold decision to take control of their financial future by becoming a Personal Finance member.
And today, I want to offer YOU the opportunity to join these folks and thousands of other members who benefit from the research and recommendations published each and every month inside Personal Finance.
It all starts with the one biotech company with a portfolio of more than 60 U.S. patents that continues to grow every year.
The company that’s about to become “The Pfizer of Pot.”
Over the next few years, cannabis-based medicines are expected to become a $82 billion a year industry…
And the company at the center of it all could become the biggest cannabis stock of all time.
Right now, you can get in on the ground floor…
Before Wall Street banks and the mainstream media take the ride to the top without you.
But you must act quickly.
Because as of today…
I Can Only Accept 500 287 New Members
If you want to take advantage of this revolutionary marijuana discovery, you need to act right away.
I have a limited number of membership spots remaining and I expect them to disappear quickly.
The moment you join Personal Finance, you’ll get instant access to:
- The “Pfizer of Pot”: How One Surprising Biotech Could Add $308,850 To Your Retirement Account (value $99)
- How To Collect Up To $55,362 Every Year From The Legal Marijuana Boom (value $59)
- The Top 10 Under-the-Radar Winners to Outsmart the Market in 2021 (value $59)
But these life-changing opportunities are just the tip of the iceberg because…
You’ll also receive instant access to my entire portfolio of open trades I’m tracking in the following sectors:
Each month, you’ll receive the latest issue of Personal Finance containing new breakthrough profit opportunities.
You’ll also receive Intra-Day FLASH Alerts any time I uncover an urgent BUY opportunity or when my research indicates it’s time to take profits on an open trade. You’ll never wonder what to do or when to do it… I’ll be with you every step of the way.
With your membership, you’ll also receive:
- Weekly Update Emails — containing important news affecting the economy, the market, or our portfolio positions.
- Confidential Members-Only Website — this secure, password-protected membership site is where you’ll have 24/7 access to all past issues of Personal Finance, FLASH Alert histories, portfolio summaries, special reports, and bonuses, and have daily opportunities to interact directly with me and the other experts in our private Stock Talk forum
- VIP Concierge Hotline — where a real live human is available whenever you have a question or concern you need handled right away.
As you can see, Personal Finance is the full package.
Becoming a member means you have a team of expert analysts doing the heavy lifting for you…
Providing the investment recommendations and support you need to generate the kind of wealth you’ve always dreamed of.
All that remains is for you to follow our monthly recommendations…
Make a quick call to your broker…
Or tap a few keystrokes inside your online brokerage account…
And you’re done.
The profits will take care of themselves.
With everything you receive as a Personal Finance member…
You might expect membership to cost thousands of dollars.
However…
Our regular price is $99 a year.
Given that you’ll receive a minimum of 12 opportunities to generate double, triple, or even quadruple-digit returns each year…
And a single recommendation could cover your annual membership fee 100 times over…
I think you’ll agree… $99 is a fair price.
However, through today’s special offer, we’re not asking anywhere near that amount.
I’ve negotiated a steep discount with my publisher…
But it’s only valid until the remaining 500 287 membership spots have been claimed.
The price is so low, I can’t advertise it here.
So you’ll have to click the green button below to get details.
When you do, you’ll also discover your trial membership is covered by two 100% money-back guarantees…
So you can join today with zero risk.
The Next Move Is Yours
The ability to produce THC, CBD, and any of marijuana’s other 100+ cannabinoids in a laboratory will revolutionize the medical marijuana industry.
Over the next few years, there could be as much as $82 billion a year at stake.
And one cutting-edge biotech company is about to lock down the lion’s share of the entire industry’s profits.
Right now, you have a choice…
You can walk away from this presentation and immediately forget everything I’ve shown you here today.
If you do that, your life will remain in pretty much the same state it was yesterday… and the day before that.
You’ll continue along your current path…
Searching for the one big investment win that will put your retirement on easy street.
Then… every time you hear news about a pot stock that’s exploded overnight, you’ll wonder if you once again missed out on the opportunity of a lifetime.
Or…
You can join Personal Finance today and claim your share of this trailblazing biotech company…
That’s on the verge of becoming “The Pfizer of Pot.”
Before their stock price goes ballistic…
Before they become a household name…
And before Wall Street insiders scoop up the returns that rightfully belong to you.
Make no mistake… this marijuana revolution will mint thousands of new millionaires.
The only question is…
Will you be one of them?
I have only 500 287 membership spots remaining today and at the discounted rate, I don’t expect them to last much longer.
So if securing your financial future is important to you…
Click the link below and join Personal Finance, while there’s still time.
I hope to welcome you as a new member soon.
(You Can Review Your Order Before It’s Final)
Thank you,
John Persinos
Managing Editor
Personal Finance
P.S. Remember, a Senate vote on the S.A.F.E Banking Act could take place within weeks. Waiting until after the vote is the wrong move. By that time, Wall Street vultures will have swarmed and swallowed the returns that should be yours. Don’t let that happen. Click the button below and get your “Pfizer of Pot” report in your hands today.
(You Can Review Your Order Before It’s Final)
Copyright © 2022 Investing Daily, a division of Capitol Information Group, Inc. In order to ensure that you are utilizing the provided information and products appropriately, please review Investing Daily’s’ terms and conditions and privacy policy pages.